IMPORTANT SAFETY INFORMATION FOR LATUDA

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
See full prescribing information for complete boxed warning.
  • Elderly patients with dementia-related psychosis treated with antipsychotic drugs are
    at an increased risk of death.
  • LATUDA is not approved for the treatment of patients with dementia-related psychosis.
Please click here for additional Important Safety Information, including Boxed Warning.
Please click here for full Prescribing Information.

Helping Your Loved One Manage Schizophrenia

As a caregiver, you know how vital your role is in helping your loved one manage schizophrenia. You are someone he or she can trust, someone he or she relies on for support, and someone who helps make important treatment decisions.

Many of the ideas in this section may already be part of your loved one's plan of care. But even if you're a seasoned caregiver, consider how some of these suggestions might help you manage the challenges you and your loved one face.

IMPORTANT SAFETY INFORMATION FOR LATUDA

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
See full prescribing information for complete boxed warning.

  • Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. 
  • LATUDA is not approved for the treatment of patients with dementia-related psychosis.

Neuroleptic malignant syndrome (NMS): NMS is a rare and potentially fatal side effect reported with LATUDA and similar medicines. Call your healthcare provider right away if you have high fever; stiff muscles; confusion; changes in pulse, heart rate, or blood pressure; sweating; or muscle pain and weakness. Treatment should be stopped if you have NMS.

Tardive dyskinesia (TD): TD is a serious and sometimes permanent side effect reported with LATUDA and similar medicines. TD includes uncontrollable movements of the face, tongue, and other parts of the body. The risk for developing TD and the chance that it will become permanent is thought to increase the longer a person takes the medicine and the more medicine a person takes over time. TD can develop after a person has been taking the medicine for a short time at low doses, although this is much less common. There is no known treatment for TD, but it may go away partially or completely if the person stops taking the medicine.

Metabolic Changes

High blood sugar: High blood sugar and diabetes have been reported with LATUDA. If you have diabetes or risk factors for diabetes, such as being overweight or a family history of diabetes, your blood sugar should be tested at the beginning of and throughout treatment with LATUDA. Complications of diabetes can be serious and even life threatening. Tell your healthcare provider if you have blood sugar problems or signs of diabetes, such as being thirsty all the time, going to the bathroom a lot, or feeling weak or hungry.

High cholesterol and triglycerides: Undesirable alterations in lipids have been observed in patients treated with atypical antipsychotics.

Weight gain: Some patients may gain weight while taking LATUDA. Your healthcare provider should check your weight regularly. Talk to your healthcare provider about ways to help control your weight, such as eating a healthy, balanced diet and exercising.

Additional Important Warnings

Pregnancy: Tell your healthcare provider if you are pregnant or if you are planning to get pregnant while taking LATUDA. Breast feeding is not recommended during treatment with LATUDA.

Tell your healthcare provider about all prescription and over-the-counter medicines you are taking or plan to take, since there are some risks for drug interactions with LATUDA. Avoid drinking alcohol while taking LATUDA.

In people with schizophrenia, the most common side effects that occurred with LATUDA were sleepiness, an inner sense of restlessness or need to move (akathisia), upset stomach, and movement abnormalities such as tremors, slow movement, or muscle stiffness (parkinsonism). 

This is not a complete summary of safety information. Please discuss the full Prescribing Information for prescription LATUDA with your healthcare provider.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

 

Sunovion

 

You are now leaving the LATUDA website. Sunovion is not responsible for the information contained in any of the linked sites.